90 Pageviews Read Stories
- EIN 26-4510094
- (617) 765-4881
- 955 Massachusetts Ave Ste 343 Cambridge MA 02139-3233 USA
- www.targetcancerfoundation.org
- Add to Favorites
Nonprofit Overview
Causes: Cancer, Cancer Research, Health
Mission: Targetcancer foundation promotes the development of lifesaving treatment protocols for rare cancers. Targetcancer foundation directly supports initiatives at the forefront of cancer treatment by funding innovative research, fostering collaborations, and raising awareness among scientists, clinicians, and patients.
Programs: The specific purposes of the organization are to raise awareness of and support for research into the causes and treatments of rare cancers. This was accomplished in the fiscal year by granting $197,170 in new research grants focusing on cholangiocarcinoma and esophageal cancer. This included $44,750 to support nabeel bardeesy's cholangiocarcinoma research at the massachusetts general hospital cancer center, completing a $125,000 grant initiated in the previous fiscal year. This grant marks the sixth year of an ongoing commitment to dr. Bardeesy's laboratory to create the most comprehensive existing research program for cholangiocarcinoma. Targetcancer foundation's approach to finding treatments for cholangiocarcinoma focuses on the key areas of supporting research, fostering collaborations, and facilitating the creation and preservation of cell lines and other tissue samples. This also included $149,920 in support of esophageal cancer research by adam bass, md at the dana-farber cancer institute. This funding represents the second half of a grant initiated in the previous fiscal year, supporting research around a new clinical trial testing immunotherapy in esophageal cancer. This funding also represents a new, $100,000 grant focusing on the role of the kras gene in esophageal cancer. This award will support new efforts to understand the unique functions of kras in esophageal cancer and to test and develop new therapies.
